c Actinomyces graevenitzii is a newly recognized Actinomyces species that is seldom isolated from clinical specimens. A case of multiple pulmonary abscesses mimicking acute pulmonary coccidioidomycosis is described in this study, and the findings indicate that this organism is an opportunistic human pathogen.
CASE REPORTA 38-year-old apparently healthy woman complained of fever and dry cough after visiting Los Angeles, CA. Her medical history did not reveal any specific illness, including acquired immune deficiency syndrome. She did not smoke or consume alcohol. During her 3-day stay, she visited the beach in California. On her way to the beach, she encountered a dust storm and inhaled a large amount of dust. Seven days after she returned to Japan (9 days after encountering the dust storm), she was admitted to a local hospital in Nagasaki owing to a progressive dry cough (clinical day 8). On admission, the vital signs of the patient were as follows: body temperature, 37.5°C; blood pressure, 99/64 mm Hg; pulse, 72 beats/min with a regular rhythm; SpO 2 , 96% in a room air condition; and respiratory rate, 16 breaths/min. Cyanosis, cardiac murmur, and breath sounds were absent. Moreover, her liver, spleen and lymph nodes were not palpable. Her white blood cell count was 7.3 ϫ 10 3 /ml, with a shift to the left (71% neutrophils), and her C-reactive protein value was 5 mg/dl (normal range, 0 to 0.3 mg/dl). The chest computed tomography (CT) images revealed multiple round lesions located on both lobes, with diameters of 0.5 to 1 cm ( Fig. 1 and 2). The radiological findings strongly suggested metastatic tumors; hence, digestive tract endoscopy and positron emission tomography (PET) of the entire body were performed. No other lesions, except the lesions in the lungs, were found to contribute to the findings. Two weeks later (clinical day 21), the multiple pulmonary lesions had grown in size by 3-fold, with partial cavity formation ( Fig. 1 and 2). Owing to the extreme rapid progression of the lesions, the patient was transferred to our hospital for further examination and treatment. An oral antibiotic, faropenem (FRPM), at 600 mg/day was given from clinical days 21 to 24. On admission (clinical day 25), we suspected acute pulmonary coccidioidomycosis because of her travel history to the U.S. West Coast and the similarities of her CT images with those of typical pulmonary Coccidioides infection (3), and we administered liposomal amphotericin B (L-AMB) at 150 mg/day intravenously on clinical day 26. We also initiated tazobactam-piperacillin (TAZ-PIPC) therapy at 18 g/day concurrently, because the presence of other bacterial infections was not completely excluded. Before the initiation of antibiotic therapy, a transbronchial biopsy (TBB) using endobronchial ultrasonography with a guide sheath was performed 48 h after the cessation of FRPM treatment. The presence of antibodies against Coccidioides was also examined before the initiation of antifungal treatment (clinical day 26). After 9 days of treatment (clinical day 35),...